Dudediligence.

Celularity Inc

CELUNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$12.1MJun ’24$9.3MSep ’24$18.1MDec ’24$11.4MMar ’25$5.7MJun ’25$5.3MSep ’25$4.1MDec ’25$3.8MMar ’26
Net income, by quarter
−$6.5MJun ’24−$16.1MSep ’24−$13.3MDec ’24−$19.8MMar ’25−$24.5MJun ’25−$23.1MSep ’25−$24.4MDec ’25$874,000Mar ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$21.3M$18.0M$22.8M$54.2M$26.6M
Gross profit$11.7M−$1.7M$6.8M$39.2M$6.5M
Operating income−$109.1M−$25.6M−$192.3M−$38.4M−$61.3M
Net income−$100.1M$14.2M−$196.3M−$57.9M−$91.7M
Operating cash flow−$110.1M−$137.9M−$38.7M−$6.4M−$13.3M
Free cash flow−$116.3M−$143.1M−$39.7M−$6.6Mnone on file
Cash$37.2M$14.0M$227,000$738,000$6.2M
Debtnone on file$37.6M$17.2Mnone on file$33.8M
Shares outstanding124.3M14.9M19.4M22.5M28.8M